间充质干细胞
神经营养因子
脚手架
脊髓损伤
细胞生物学
再生(生物学)
神经营养素
化学
胶质瘢痕
脑源性神经营养因子
脊髓
组织工程
MAPK/ERK通路
睫状神经营养因子
中枢神经系统
污渍
多糖
胶质细胞源性神经生长因子
神经科学
体内
再生医学
脊髓性肌萎缩
转录组
作者
Zhongqing Ji,Jinming Liu,Jianwei Xu,Yu Zhang,Zhong Wentao,Yanan Hu,Huanxiang Zhang,Yixin Shen
标识
DOI:10.3389/fbioe.2026.1838918
摘要
Objective: Following spinal cord injury (SCI), glial scarring mediated by chondroitin sulfate proteoglycans (CSPGs), coupled with insufficient neurotrophic support, hinders axonal regeneration. Furthermore, the lack of physical support at the injury site during the acute phase compromises cell survival and engraftment. To overcome these challenges, we developed a three-dimensional channeled porous-GelMA scaffold (CPGS) that provides spatial guidance and structural support. This scaffold is integrated with genetically engineered MSCs designed to continuously release brain-derived neurotrophic factor (BDNF) and inducibly express Chondroitinase ABC (ChABC). This integrated system combines therapeutic factors, stem cells, and tissue engineering to improve the injured microenvironment and promote neural regeneration after SCI. Methods: MSCs were genetically engineered for continuous BDNF expression and doxycycline (Dox)-inducible ChABC expression. RT-qPCR and Western blotting were used to validate expression levels. We performed transcriptomic analysis and protein-level verification to assess the activation of key signaling pathways. A porous GelMA-based CPGS, featuring longitudinal guidance cues, was fabricated and characterized for its structure and mechanical properties. BDNF/ChABC-MSCs were then seeded into the CPGS to create an integrated system, which was subsequently evaluated in a rat SCI model. Results: studies showed that the BDNF/ChABC-MSCs-CPGS system significantly improved BBB scores, markedly reduced lesion size and collagen deposition, decreased CS-56 expression, and increased expression of the axonal regeneration markers, NF-H and GAP43. Conclusion: The BDNF/ChABC-MSCs-CPGS integrated system enhances the SCI lesion microenvironment through structural guidance and biochemical modulation, thereby promoting axonal regeneration and functional recovery. This approach presents a novel strategy for combined tissue engineering and stem cell therapy in SCI treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI